Roles of sex steroid receptors and cell cycle regulation in pathogenesis of pelvic organ prolapse

Current Opinion in Obstetrics and Gynecology

Volumn 18, Issue 5, 2006, Pages 551-554

  Chung, Da Jung ^a   Bai, Sang Wook ^a  

^a Yonsei University   (South Korea)

Author keywords

Cell proliferation and apoptosis; Pathogenesis of POP; Sex steroid receptors; Sex steroids

Indexed keywords

CENTCHROMAN; ESTROGEN; ESTROGEN RECEPTOR; HORMONE RECEPTOR; IDOXIFENE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SEX HORMONE; TAMOXIFEN;

APOPTOSIS; BREAST CANCER; CELL CYCLE; CELL CYCLE REGULATION; CELL PROLIFERATION; CLINICAL TRIAL; COLLAGEN METABOLISM; DISEASE COURSE; HUMAN; IMMUNOHISTOCHEMISTRY; LIGAMENT; OSTEOPOROSIS; PATHOGENESIS; PELVIC ORGAN PROLAPSE; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; REVIEW; URINE INCONTINENCE;

APOPTOSIS; CELL DIVISION; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; OVARY; RECEPTORS, STEROID; UTERINE PROLAPSE;

EID: 33748282945     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gco.0000242959.63362.1e     Document Type: Review

References (37)

1. Ulmsten U, Ekman G, Giertz G, Malmstrom A. Different biochemical composition of connective tissue in continent and stress incontinent women. Acta Obstet Gynecol Scand 1987; 66:455-457.
2. Norton PA. Pelvic floor disorders: The role of fascia and ligaments. Clin Obstet Gynecol 1993; 36:926-938.
3. Bump RC, Norton PA. Epidemiology and natural history of pelvic floor dysfunction. Obstet Gynecol Clin North Am 1998; 25:723-746.
4. Mokrzycki ML, Mittal K, Smilen SW, et al. Estrogen and progesterone receptors in the uterosacral ligament. Obstet Gynecol 1997; 90:402-404.
5. Smith P, Heimer G, Norgren A, Ulmsten U. Localization of steroid hormone receptors in the pelvic muscles. Eur J Obstet Gynecol Reprod Biol 1993; 50:83-85.
6. Franz H, Wendler D, Oettling G. Immunohistochemical assessment of steroid hormone receptors in tissues of the anal canal implications for anal incontinence. Acta Obstet Gynecol Scand 1996; 75:892-895.
7. Weihua Z, Makela S, Andersson LC, et al. A role for estrogen receptor beta in the regulation of growth of the ventral prostate. Proc Natl Acad Sci U S A 2001; 98:6330-6335.
8. Valimaa H, Savolainen S, Soukka T, et al. Estrogen receptor-beta is the predominant estrogen receptor subtype in human oral epithelium and salivary glands. J Endocrinol 2004; 180:55-62.
9. Makinen S, Makela S, Weihua Z, et al. Localization of oestrogen receptors alpha and beta in human testis. Mol Hum Reprod 2001; 7:497-503.
10. Cheng G, Weihua Z, Makinen S, et al. A role for the androgen receptor in follicular atresia of estrogen receptor beta knockout mouse ovary. Biol Reprod 2002; 66:77-84.
11. Lindner V, Kim SK, Karas RH, et al. Increased expression of estrogen receptor-beta mRNA in male blood vessels after vascular injury. Circ Res 1998; 83:224-229.
12. Barchiesi F, Jackson EK, Imthurn B, et al. Differential regulation of estrogen receptor subtypes alpha and beta in human aortic smooth muscle cells by oligonucleotides and estradiol. J Clin Endocrinol Metab 2004; 89:2373-2381.
13. Shim GJ, Wang L, Andersson S, et al. Disruption of the estrogen receptor beta gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis. Proc Natl Acad Sci U S A 2003; 100:6694-6699.
14. Ewies AA, Al-Azzawi F, Thompson J. Changes in extracellular matrix proteins in the cardinal ligaments of postmenopausal women with or without prolapse: a computerized immunohistomorphometric analysis. Hum Reprod 2003; 18:2189-2219.
15. Yamamoto K, Yamamoto M, Akazawa K, et al. Decrease in elastin gene expression and protein synthesis in fibroblasts derived from cardinal ligaments of patients with prolapsus uteri. Cell Biol Int 1997; 21:605-611.
16. Zhang J, Salamonsen LA. In vivo evidence for active matrix metalloproteinases in human endometrium supports their role in tissue breakdown at menstruation. J Clin Endocrinol Metab 2002; 87:2346-2351.
17. McIntush EW, Smith MF. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in ovarian function. Rev Reprod 1998; 3:23-30.
18. Brincat M, Versi E, Moniz CF, et al. Skin collagen changes in postmenopausal women receiving different regimens of estrogen therapy. Obstet Gynecol 1987; 70:123-127.
19. Jackson SR, Avery NC, Tarton JF, et al. Changes in metabolism of collagen in genitourinary prolapse. Lancet 1996; 347:1658-1661.
20. Moalli PA, Klingensmith WL, Meyn LA, Zyczynski HM. Regulation of matrix metalloproteinase expression by estrogen in fibroblasts that are derived from the pelvic floor. Am J Obstet Gynecol 2002; 187:72-79.
21. Helvering LM, Adrian MD, Geiser AG, et al. Differential effects of estrogen and raloxifene on messenger RNA and matrix metalloproteinase 2 activity in the rat uterus. Biol Reprod 2005; 72:830-841.
22. Potier M, Elliot SJ, Tack I, et al. Expression and regulation of estrogen receptors in mesangial cells: influence on matrix metalloproteinase-9. J Am Soc Nephrol 2001; 12:241-251.
23. Wingrove CS, Garr E, Godsland IF, Stevenson JC. 17Beta-oestradiol enhances release of matrix metalloproteinase-2 from human vascular smooth muscle cells. Biochim Biophys Acta 1998; 1406:169-174.
24. Marin-Castano ME, Elliot JS, Potier M, et al. Regulation of estrogen receptors and MMP-2 expression by estrogens in human retinal pigment epithelium. Invest Ophthalmol Vis Sci 2003; 44:50-59.
25. Liu YM, Choy KW, Lui WT, et al. 17beta-estradiol suppresses proliferation of fibroblasts derived from cardinal ligaments in patients with or without pelvic organ prolapse. Hum Reprod 2006; 21:303-308.
26. Cox DA, Helvering LM. Extracellular matrix integrity: A possible mechanism for differential clinical effects among selective estrogen receptor modulators and estrogens? Mol Cell Endocrinol 2006; 247:53-59. This review article describes how selective estrogen receptor modulators and estrogens act on the integrity of extracellular matrix related to female urogenital tracts and suggests further research directions for SERMs.
27. Goldstein SR, Nanavati N. Adverse events that are associated with the selective estrogen receptor modulator levormeloxifene in an aborted phase III osteoporosis treatment study. Am J Obstet Gynecol 2002; 187:521-527.
28. Hendrix SL, Cochrane BB, Nygaard IE, et al. Effects of estrogen with and without progestin on urinary incontinence. JAMA 2005; 293:935-948.
29. Fisher B, Dignam J, Bryant J, Wolmark N. Five versus more than five years of tamoxifen for lymph nodenegative breast cancer: updated findings from the national surgical adjuvant breast and bowel project B-14 randomized trial. J Natl Cancer Inst 2001; 93:684-690.
30. Goldstein SR, Johnson S, Watts NB, et al. Incidence of urinary incontinence in postmenopausal women treated with raloxifene or estrogen. Menopause 2005; 12:160-164.
31. Massaro D, Massaro GD. Estrogen regulates pulmonary alveolar formation, loss and regulation in mice. Am J Physiol Lung Cell Mol Physiol 2004; 287:L1154-L1159.
32. Zhou W, Koldzic-Zivanovic N, Clarke CH, et al. Selective estrogen receptor modulator effects in the rat brain. Neuroendocrinology 2002; 75:24-33.
33. Koehler KF, Helguero LA, Haldose'n LA, et al. Reflections on the discovery and significance of estrogen receptor alpha. Endocrine Reviews 2005; 26:465-478. This article provides an in-depth and wide review of how estrogen receptor subtypes are involved in almost all biological systems.
34. Lang JH, Zhu L, Sun ZJ, Chen J. Estrogen levels and estrogen receptors in patients with stress urinary incontinence and pelvic organ prolapse. Int J Gynecol Obstet 2003; 80:35-39.
35. Bai SW, Chung DJ, Yoon JM, et al. Roles of estrogen receptor, progesterone receptor, p53 and p21 in pathogenesis of pelvic organ prolapse. Int Urogynecol J 2005; 16:492-496.
36. Ewies AA, Thompson J, Al-azzawi F. Changes in gonadal steroid receptors in the cardinal ligaments of prolapsed uteri: immunohistomorphometric data. Hum Reprod 2004; 19:1622-1628.
37. Yamamoto M, Aoyagi M, Akazawa K, et al. Decrease in p53 protein in cultured cardinal ligament fibroblasts from patients with prolapsus uteri. Cell Biol Int 1998; 22:31-40.